Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Cervical Cancer

Free Subscription Articles published in Oncol Rep Retrieve available abstracts of 84 articles: HTML format

Single Articles

July 2021
1. SONG X, Shi B, Huang K, Zhang W, et al
   [Retracted] miR133a inhibits cervical cancer growth by targeting EGFR.
   Oncol Rep. 2021;46.
   PubMed     Abstract available
   
   
   
2. CHU J, Gao J, Wang J, Li L, et al
   Mechanism of hydrogen on cervical cancer suppression revealed by highthroughput RNA sequencing.
   Oncol Rep. 2021;46.
   PubMed     Abstract available
   
   
   June 2021
3. DEZEN T, Rossini RR, Spadin MD, Da Cunha Andrade CEM, et al
   Accuracy of MRI for diagnosing pelvic and paraaortic lymph node metastasis in cervical cancer.
   Oncol Rep. 2021;45.
   PubMed     Abstract available
   
   
   May 2021
4. WANG J, Xiang F, Liu X, Ma X, et al
   HPV E7 affects the function of cervical cancer cells via the TAL1/lncEBIC/KLHDC7B axis.
   Oncol Rep. 2021;45.
   PubMed     Abstract available
   
   
   
5. YANG X, Du H, Bian W, Li Q, et al
   FOXD3AS1/miR1283p/LIMK1 axis regulates cervical cancer progression.
   Oncol Rep. 2021;45.
   PubMed     Abstract available
   
   
   
6. OUYANG F, Liu J, Xia M, Lin C, et al
   [Corrigendum] GINS2 is a novel prognostic biomarker and promotes tumor progression in earlystage cervical cancer.
   Oncol Rep. 2021;45.
   PubMed     Abstract available
   
   
   April 2021
7. YOU X, Wang Y, Meng J, Han S, et al
   Exosomal miR663b exposed to TGFbeta1 promotes cervical cancer metastasis and epithelialmesenchymal transition by targeting MGAT3.
   Oncol Rep. 2021;45:1.
   PubMed     Abstract available
   
   
   November 2020
8. LIU H, Li Y, Zhang J, Wu N, et al
   ErbB2 Receptor Tyrosine Kinase 2 is negatively regulated by the p53responsive microRNA31845p in cervical cancer cells.
   Oncol Rep. 2020 Nov 19. doi: 10.3892/or.2020.7862.
   PubMed     Abstract available
   
   
   October 2020
9. WANG A, Liu L, Yuan M, Han S, et al
   Role and mechanism of FLNa and UCP2 in the development of cervical cancer.
   Oncol Rep. 2020 Oct 21. doi: 10.3892/or.2020.7819.
   PubMed     Abstract available
   
   
   July 2020
10. SI J, Zhang J, Gan L, Guo M, et al
    The effects of the Wnt/betacatenin signaling pathway on apoptosis in HeLa cells induced by carbon ion irradiation.
    Oncol Rep. 2020;44:303-312.
    PubMed     Abstract available
    
    
    May 2020
11. WU G, Long Y, Lu Y, Feng Y, et al
    Kindlin2 suppresses cervical cancer cell migration through AKT/mTORmediated autophagy induction.
    Oncol Rep. 2020 May 4. doi: 10.3892/or.2020.7603.
    PubMed     Abstract available
    
    
    
12. MA HR, Cao L, Wang F, Cheng C, et al
    Filamin B extensively regulates transcription and alternative splicing, and is associated with apoptosis in HeLa cells.
    Oncol Rep. 2020;43:1536-1546.
    PubMed     Abstract available
    
    
    April 2020
13. ICHIKAWA R, Kawasaki R, Iwata A, Otani S, et al
    MicroRNA1263p suppresses HeLa cell proliferation, migration and invasion, and increases apoptosis via the PI3K/PDK1/AKT pathway.
    Oncol Rep. 2020;43:1300-1308.
    PubMed     Abstract available
    
    
    February 2020
14. CHEN X, Liu W, Guo X, Huang S, et al
    Ropivacaine inhibits cervical cancer cell growth via suppression of the miR96/MEG2/pSTAT3 axis.
    Oncol Rep. 2020 Feb 26. doi: 10.3892/or.2020.7521.
    PubMed     Abstract available
    
    
    November 2019
15. LV R, Zhang QW
    The long noncoding RNA FTH1P3 promotes the proliferation and metastasis of cervical cancer through microRNA145.
    Oncol Rep. 2019 Nov 20. doi: 10.3892/or.2019.7413.
    PubMed     Abstract available
    
    
    October 2019
16. XU Q, Chen C, Liu B, Lin Y, et al
    Association of iRhom1 and iRhom2 expression with prognosis in patients with cervical cancer and possible signaling pathways.
    Oncol Rep. 2019 Oct 25. doi: 10.3892/or.2019.7389.
    PubMed     Abstract available
    
    
    
17. ZHANG L, Tian S, Pei M, Zhao M, et al
    Crosstalk between histone modification and DNA methylation orchestrates the epigenetic regulation of the costimulatory factors, Tim3 and galectin9, in cervical cancer.
    Oncol Rep. 2019 Oct 24. doi: 10.3892/or.2019.7388.
    PubMed     Abstract available
    
    
    
18. WANG W, Zhou Y, Wei R, Jiang G, et al
    Bradykinin promotes proliferation, migration, and invasion of cervical cancer cells through STAT3 signaling pathways.
    Oncol Rep. 2019 Oct 18. doi: 10.3892/or.2019.7380.
    PubMed     Abstract available
    
    
    September 2019
19. CAO P, Wang Y, Lv Y, Jiang N, et al
    PI3K p110alpha inhibition sensitizes cervical cancer cells with aberrant PI3K signaling activation to PARP inhibitor BMN673.
    Oncol Rep. 2019 Sep 13. doi: 10.3892/or.2019.7313.
    PubMed     Abstract available
    
    
    
20. WU Z, Li J, Zhang Y, Hu L, et al
    Synchronous coexpression of Id1 and nuclear NFkappaB p65 promotes cervical cancer progression and malignancy, and is associated with a poor prognosis and chemosensitivity.
    Oncol Rep. 2019 Sep 5. doi: 10.3892/or.2019.7301.
    PubMed     Abstract available
    
    
    August 2019
21. LIU Z, Zhu W, Kong X, Chen X, et al
    Tanshinone IIA inhibits glucose metabolism leading to apoptosis in cervical cancer.
    Oncol Rep. 2019 Aug 27. doi: 10.3892/or.2019.7294.
    PubMed     Abstract available
    
    
    
22. AEDO-AGUILERA V, Carrillo-Beltran D, Calaf GM, Munoz JP, et al
    Curcumin decreases epithelialmesenchymal transition by a Pirindependent mechanism in cervical cancer cells.
    Oncol Rep. 2019 Aug 21. doi: 10.3892/or.2019.7288.
    PubMed     Abstract available
    
    
    
23. PAPPA KI, Lygirou V, Kontostathi G, Makridakis M, et al
    High resolution analysis of the intracellular proteome of cervical cancer cell lines unveils novel regulators of cervical carcinogenesis.
    Oncol Rep. 2019 Aug 8. doi: 10.3892/or.2019.7269.
    PubMed     Abstract available
    
    
    July 2019
24. DAI B, Yu R, Fan M, Yang T, et al
    HMQTF2 suppresses migration of the human cervical cancer HeLa cells by reversing EMT via the PI3K/Akt signaling pathway.
    Oncol Rep. 2019 Jul 23. doi: 10.3892/or.2019.7245.
    PubMed     Abstract available
    
    
    
25. CHENG Y, Qin K, Huang N, Zhou Z, et al
    Cytokeratin 18 regulates the transcription and alternative splicing of apoptoticrelated genes and pathways in HeLa cells.
    Oncol Rep. 2019;42:301-312.
    PubMed     Abstract available
    
    
    June 2019
26. XU R, Chen L, Yang WT
    Aberrantly elevated Bmi1 promotes cervical cancer tumorigenicity and tumor sphere formation via enhanced transcriptional regulation of Sox2 genes.
    Oncol Rep. 2019 Jun 6. doi: 10.3892/or.2019.7188.
    PubMed     Abstract available
    
    
    April 2019
27. SHI C, Yang Y, Zhang L, Zhang T, et al
    Optimal subset of signature miRNAs consisting of 7 miRNAs that can serve as a novel diagnostic and prognostic predictor for the progression of cervical cancer.
    Oncol Rep. 2019 Apr 3. doi: 10.3892/or.2019.7097.
    PubMed     Abstract available
    
    
    March 2019
28. ZHANG L, Zhou J, Qin X, Huang H, et al
    Astragaloside IV inhibits the invasion and metastasis of SiHa cervical cancer cells via the TGFbeta1mediated PI3K and MAPK pathways.
    Oncol Rep. 2019 Mar 13. doi: 10.3892/or.2019.7062.
    PubMed     Abstract available
    
    
    
29. LI T, Li M, Xu C, Xu X, et al
    miR146a regulates the function of Th17 cell differentiation to modulate cervical cancer cell growth and apoptosis through NFkappaB signaling by targeting TRAF6.
    Oncol Rep. 2019 Mar 7. doi: 10.3892/or.2019.7046.
    PubMed     Abstract available
    
    
    
30. ZHENG M, Zhou Q, Liu X, Wang C, et al
    CTHRC1 overexpression promotes cervical carcinoma progression by activating the Wnt/PCP signaling pathway.
    Oncol Rep. 2019;41:1531-1538.
    PubMed     Abstract available
    
    
    
31. XING D, Lu J
    Distinctive clinicopathological features and diseasespecific survival of adenoid cystic carcinoma and adenoid basal carcinoma in the lower female genital tract.
    Oncol Rep. 2019;41:1769-1778.
    PubMed     Abstract available
    
    
    February 2019
32. BO H, Fan L, Gong Z, Liu Z, et al
    Upregulation and hypomethylation of lncRNA AFAP1AS1 predicts a poor prognosis and promotes the migration and invasion of cervical cancer.
    Oncol Rep. 2019 Feb 21. doi: 10.3892/or.2019.7027.
    PubMed     Abstract available
    
    
    
33. YI Y, Liu Y, Wu W, Wu K, et al
    Reconstruction and analysis of circRNAmiRNAmRNA network in the pathology of cervical cancer.
    Oncol Rep. 2019 Feb 21. doi: 10.3892/or.2019.7028.
    PubMed     Abstract available
    
    
    
34. SU X, Zhang L, Kang H, Zhang B, et al
    Mechanical, nanomorphological and biological reconstruction of earlystage apoptosis in HeLa cells induced by cytochalasin B.
    Oncol Rep. 2019;41:928-938.
    PubMed     Abstract available
    
    
    
35. LI X, Wu X, Li Y, Cui Y, et al
    Promoter hypermethylation of SOX11 promotes the progression of cervical cancer in vitro and in vivo.
    Oncol Rep. 2019 Feb 1. doi: 10.3892/or.2019.6993.
    PubMed     Abstract available
    
    
    November 2018
36. VAZQUEZ-MELLADO MJ, Cortes-Ballinas LG, Blanco-Flores IC, Aguilar C, et al
    Erythropoietin promotes expression of survivin via STAT3 activation and reduces sensitivity to cisplatin in cervical cancer cells.
    Oncol Rep. 2018 Nov 27. doi: 10.3892/or.2018.6890.
    PubMed     Abstract available
    
    
    
37. WANG Z, Yu C, Wang H
    HOXA5 inhibits the proliferation and induces the apoptosis of cervical cancer cells via regulation of protein kinase B and p27.
    Oncol Rep. 2018 Nov 20. doi: 10.3892/or.2018.6874.
    PubMed     Abstract available
    
    
    
38. CHEN X, Song L, Hou Y, Li F, et al
    Reactive oxygen species induced by icaritin promote DNA strand breaks and apoptosis in human cervical cancer cells.
    Oncol Rep. 2018 Nov 12. doi: 10.3892/or.2018.6864.
    PubMed     Abstract available
    
    
    
39. ZHANG D, Dong Y, Zhao Y, Zhou C, et al
    Sinomenine hydrochloride sensitizes cervical cancer cells to ionizing radiation by impairing DNA damage response.
    Oncol Rep. 2018;40:2886-2895.
    PubMed     Abstract available
    
    
    October 2018
40. LIAO H, Pan Y, Pan Y, Shen J, et al
    MicroRNA874 is downregulated in cervical cancer and inhibits cancer progression by directly targeting ETS1.
    Oncol Rep. 2018;40:2389-2398.
    PubMed     Abstract available
    
    
    September 2018
41. RIERA-LEAL A, Ramirez De Arellano A, Ramirez-Lopez IG, Lopez-Pulido EI, et al
    Effects of 60 kDa prolactin and estradiol on metabolism and cell survival in cervical cancer: Coexpression of their hormonal receptors during cancer progression.
    Oncol Rep. 2018 Sep 28. doi: 10.3892/or.2018.6743.
    PubMed     Abstract available
    
    
    
42. XU J, Zhu W, Chen L, Liu L, et al
    MicroRNA433 inhibits cell growth and induces apoptosis in human cervical cancer through PI3K/AKT signaling by targeting FAK.
    Oncol Rep. 2018 Sep 21. doi: 10.3892/or.2018.6718.
    PubMed     Abstract available
    
    
    August 2018
43. CHE Y, Li J, Li Z, Li J, et al
    Osthole enhances antitumor activity and irradiation sensitivity of cervical cancer cells by suppressing ATM/NFkappaB signaling.
    Oncol Rep. 2018;40:737-747.
    PubMed     Abstract available
    
    
    
44. YUAN Y, Ye HQ, Ren QC
    Proliferative role of BDNF/TrkB signaling is associated with anoikis resistance in cervical cancer.
    Oncol Rep. 2018;40:621-634.
    PubMed     Abstract available
    
    
    July 2018
45. CHOI Y, Chang JE, Jheon S, Han SJ, et al
    Enhanced production of reactive oxygen species in HeLa cells under concurrent lowdose carboplatin and Photofrin(R) photodynamic therapy.
    Oncol Rep. 2018;40:339-345.
    PubMed     Abstract available
    
    
    June 2018
46. ZHAN Y, Zhang H, Dai B, Zhang Y, et al
    A novel biphenyl urea compound, TPD7, stimulates apoptosis through modulating Fas signaling and Bcl-2 family proteins in cervical cancer.
    Oncol Rep. 2018 Jun 4. doi: 10.3892/or.2018.6472.
    PubMed     Abstract available
    
    
    April 2018
47. HU Q, Song J, Ding B, Cui Y, et al
    miR-146a promotes cervical cancer cell viability via targeting IRAK1 and TRAF6.
    Oncol Rep. 2018 Apr 23. doi: 10.3892/or.2018.6391.
    PubMed     Abstract available
    
    
    
48. CHEN Y, Zhuang H, Chen X, Shi Z, et al
    Spermidineinduced growth inhibition and apoptosis via autophagic activation in cervical cancer.
    Oncol Rep. 2018 Apr 18. doi: 10.3892/or.2018.6377.
    PubMed     Abstract available
    
    
    March 2018
49. IVANOV MK, Titov SE, Glushkov SA, Dzyubenko VV, et al
    Detection of high-grade neoplasia in air-dried cervical PAP smears by a microRNA-based classifier.
    Oncol Rep. 2018;39:1099-1111.
    PubMed     Abstract available
    
    
    February 2018
50. PAPPA KI, Kontostathi G, Lygirou V, Zoidakis J, et al
    Novel structural approaches concerning HPV proteins: Insight into targeted therapies for cervical cancer (Review).
    Oncol Rep. 2018 Feb 9. doi: 10.3892/or.2018.6257.
    PubMed     Abstract available
    
    
    January 2018
51. LI F, Wang Z, Lu G
    TRIM28 promotes cervical cancer growth through the mTOR signaling pathway.
    Oncol Rep. 2018 Jan 26. doi: 10.3892/or.2018.6235.
    PubMed     Abstract available
    
    
    
52. RAMIREZ DE ARELLANO A, Riera Leal A, Lopez-Pulido EI, Gonzalez-Lucano LR, et al
    A 60 kDa prolactin variant secreted by cervical cancer cells modulates apoptosis and cytokine production.
    Oncol Rep. 2018 Jan 19. doi: 10.3892/or.2018.6222.
    PubMed     Abstract available
    
    
    
53. PEDROZA-TORRES A, Campos-Parra AD, Millan-Catalan O, Loissell-Baltazar YA, et al
    MicroRNA-125 modulates radioresistance through targeting p21 in cervical cancer.
    Oncol Rep. 2018 Jan 18. doi: 10.3892/or.2018.6219.
    PubMed     Abstract available
    
    
    
54. SHI X, Ran L, Liu Y, Zhong SH, et al
    Knockdown of hnRNP A2/B1 inhibits cell proliferation, invasion and cell cycle triggering apoptosis in cervical cancer via PI3K/AKT signaling pathway.
    Oncol Rep. 2018 Jan 5. doi: 10.3892/or.2018.6195.
    PubMed     Abstract available
    
    
    December 2017
55. LIANG C, Ding J, Yang Y, Deng L, et al
    MicroRNA-433 inhibits cervical cancer progression by directly targeting metadherin to regulate the AKT and beta-catenin signalling pathways.
    Oncol Rep. 2017;38:3639-3649.
    PubMed     Abstract available
    
    
    November 2017
56. HOU C, Zhuang Z, Deng X, Xu Y, et al
    Knockdown of Trio by CRISPR/Cas9 suppresses migration and invasion of cervical cancer cells.
    Oncol Rep. 2017 Nov 28. doi: 10.3892/or.2017.6117.
    PubMed     Abstract available
    
    
    October 2017
57. EOH KJ, Paek J, Kim SW, Kim HJ, et al
    Long non-coding RNA, steroid receptor RNA activator (SRA), induces tumor proliferation and invasion through the NOTCH pathway in cervical cancer cell lines.
    Oncol Rep. 2017 Oct 11. doi: 10.3892/or.2017.6023.
    PubMed     Abstract available
    
    
    September 2017
58. WANG Z, He S, Guo P, Guo X, et al
    MicroRNA-1297 inhibits metastasis and epithelial-mesenchymal transition by targeting AEG-1 in cervical cancer.
    Oncol Rep. 2017 Sep 20. doi: 10.3892/or.2017.5979.
    PubMed     Abstract available
    
    
    
59. JIANG Y, Ren W, Wang W, Xia J, et al
    Inhibitor of beta-catenin and TCF (ICAT) promotes cervical cancer growth and metastasis by disrupting E-cadherin/beta-catenin complex.
    Oncol Rep. 2017 Sep 18. doi: 10.3892/or.2017.5962.
    PubMed     Abstract available
    
    
    August 2017
60. LIANG H, Luo R, Chen X, Zhao Y, et al
    miR-187 inhibits the growth of cervical cancer cells by targeting FGF9.
    Oncol Rep. 2017 Aug 23. doi: 10.3892/or.2017.5916.
    PubMed     Abstract available
    
    
    
61. DONG J, Su M, Chang W, Zhang K, et al
    Long non-coding RNAs on the stage of cervical cancer (Review).
    Oncol Rep. 2017 Aug 14. doi: 10.3892/or.2017.5905.
    PubMed     Abstract available
    
    
    July 2017
62. LI X, Zhou Q, Tao L, Yu C, et al
    MicroRNA-106a promotes cell migration and invasion by targeting tissue inhibitor of matrix metalloproteinase 2 in cervical cancer.
    Oncol Rep. 2017 Jul 18. doi: 10.3892/or.2017.5832.
    PubMed     Abstract available
    
    
    
63. LI X, Wang H, Du X, Yu W, et al
    Lactobacilli inhibit cervical cancer cell migration in vitro and reduce tumor burden in vivo through upregulation of E-cadherin.
    Oncol Rep. 2017 Jul 5. doi: 10.3892/or.2017.5791.
    PubMed     Abstract available
    
    
    
64. WU X, Zhou J, Cai D, Li M, et al
    Matrine inhibits the metastatic properties of human cervical cancer cells via downregulating the p38 signaling pathway.
    Oncol Rep. 2017 Jul 3. doi: 10.3892/or.2017.5787.
    PubMed     Abstract available
    
    
    
65. ZHOU S, Xiao Y, Zhuang Y, Liu Y, et al
    Knockdown of homeobox containing 1 increases the radiosensitivity of cervical cancer cells through telomere shortening.
    Oncol Rep. 2017;38:515-521.
    PubMed     Abstract available
    
    
    June 2017
66. LI Y, Zhang J, Han S, Qian Q, et al
    B7-H3 promotes the proliferation, migration and invasiveness of cervical cancer cells and is an indicator of poor prognosis.
    Oncol Rep. 2017 Jun 19. doi: 10.3892/or.2017.5730.
    PubMed     Abstract available
    
    
    
67. XU X, Zou L, Yao Q, Zhang Y, et al
    Silencing DEK downregulates cervical cancer tumorigenesis and metastasis via the DEK/p-Ser9-GSK-3beta/p-Tyr216-GSK-3beta/beta-catenin axis.
    Oncol Rep. 2017 Jun 14. doi: 10.3892/or.2017.5721.
    PubMed     Abstract available
    
    
    
68. WANG KS, Lv Y, Wang Z, Ma J, et al
    Imperatorin efficiently blocks TNF-alpha-mediated activation of ROS/PI3K/Akt/NF-kappaB pathway.
    Oncol Rep. 2017;37:3397-3404.
    PubMed     Abstract available
    
    
    May 2017
69. LUAN X, Wang Y
    Long non-coding RNA XLOC_006390 promotes cervical cancer proliferation and metastasis through the regulation of SET domain containing 8.
    Oncol Rep. 2017 May 23. doi: 10.3892/or.2017.5663.
    PubMed     Abstract available
    
    
    
70. OUYANG F, Liu J, Xia M, Lin C, et al
    GINS2 is a novel prognostic biomarker and promotes tumor progression in early-stage cervical cancer.
    Oncol Rep. 2017;37:2652-2662.
    PubMed     Abstract available
    
    
    
71. LI W, Liang J, Zhang Z, Lou H, et al
    MicroRNA-329-3p targets MAPK1 to suppress cell proliferation, migration and invasion in cervical cancer.
    Oncol Rep. 2017;37:2743-2750.
    PubMed     Abstract available
    
    
    
72. SUN CY, Chu ZB, Huang J, Chen L, et al
    siRNA-mediated inhibition of endogenous brainderived neurotrophic factor gene modulates the biological behavior of HeLa cells.
    Oncol Rep. 2017;37:2751-2760.
    PubMed     Abstract available
    
    
    March 2017
73. HAN S, Li Y, Zhang J, Liu L, et al
    Roles of immune inhibitory molecule B7-H4 in cervical cancer.
    Oncol Rep. 2017 Mar 1. doi: 10.3892/or.2017.5481.
    PubMed     Abstract available
    
    
    
74. LIN W, Feng M, Chen G, Zhou Z, et al
    Characterization of the microRNA profile in early-stage cervical squamous cell carcinoma by next-generation sequencing.
    Oncol Rep. 2017;37:1477-1486.
    PubMed     Abstract available
    
    
    
75. DONG W, Sun S, Cao X, Cui Y, et al
    Exposure to TNFalpha combined with TGFbeta induces carcinogenesis in vitro via NF-kappaB/Twist axis.
    Oncol Rep. 2017;37:1873-1882.
    PubMed     Abstract available
    
    
    February 2017
76. YIN Z, Sun Y, Ge S, Sun J, et al
    Epigenetic activation of WHSC1 functions as an oncogene and is associated with poor prognosis in cervical cancer.
    Oncol Rep. 2017 Feb 17. doi: 10.3892/or.2017.5463.
    PubMed     Abstract available
    
    
    
77. YIN F, Wang N, Wang S, Yu F, et al
    HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3.
    Oncol Rep. 2017 Feb 17. doi: 10.3892/or.2017.5465.
    PubMed     Abstract available
    
    
    
78. PANG X, Zhang Y, Zhang S
    High-mobility group box 1 is overexpressed in cervical carcinoma and promotes cell invasion and migration in vitro.
    Oncol Rep. 2017;37:831-840.
    PubMed     Abstract available
    
    
    November 2016
79. SHI C, Zhang Z
    MicroRNA-362 is downregulated in cervical cancer and inhibits cell proliferation, migration and invasion by directly targeting SIX1.
    Oncol Rep. 2016 Nov 15. doi: 10.3892/or.2016.5242.
    PubMed     Abstract available
    
    
    October 2016
80. WU T, Chen X, Peng R, Liu H, et al
    Let7a suppresses cell proliferation via the TGFbeta/SMAD signaling pathway in cervical cancer.
    Oncol Rep. 2016 Oct 11. doi: 10.3892/or.2016.5160.
    PubMed     Abstract available
    
    
    
81. ZHANG X, Cai D, Meng L, Wang B, et al
    MicroRNA-124 inhibits proliferation, invasion, migration and epithelial-mesenchymal transition of cervical carcinoma cells by targeting astrocyte-elevated gene-1.
    Oncol Rep. 2016;36:2321-8.
    PubMed     Abstract available
    
    
    July 2016
82. PEI Z, Zeng J, Gao Y, Li F, et al
    Oxymatrine inhibits the proliferation of CaSki cells via downregulating HPV16E7 expression.
    Oncol Rep. 2016;36:291-8.
    PubMed     Abstract available
    
    
    May 2016
83. DING Y, Yu AQ, Wang XL, Guo XR, et al
    Forced expression of Nanog with mRNA synthesized in vitro to evaluate the malignancy of HeLa cells through acquiring cancer stem cell phenotypes.
    Oncol Rep. 2016;35:2643-50.
    PubMed     Abstract available
    
    
    March 2016
84. YAO J, Deng B, Zheng L, Dou L, et al
    miR-27b is upregulated in cervical carcinogenesis and promotes cell growth and invasion by regulating CDH11 and epithelial-mesenchymal transition.
    Oncol Rep. 2016;35:1645-51.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: